Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies

International Journal of Hematology

Volumn 88, Issue 5, 2009, Pages 508-515

  Auberger, Jutta ^a   Lass Flörl, Cornelia ^b   Ulmer, Hanno ^b   Nogler Semenitz, Elisabeth ^c   Clausen, Johannes ^a   Gunsilius, Eberhard ^a   Einsele, Hermann ^d   Gastl, Günther ^a   Nachbaur, David ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Antifungal therapy; Epidemiology; Hematological malignancy; Invasive fungal infection

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; COTRIMOXAZOLE; FLUCONAZOLE; ITRACONAZOLE; POSACONAZOLE; VALACICLOVIR; VORICONAZOLE; ANTIFUNGAL AGENT;

ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; ASPERGILLUS TERREUS; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANDIDA; CANDIDEMIA; CAUSE OF DEATH; CHICKENPOX; DISEASE ACTIVITY; FEMALE; HEMATOLOGIC MALIGNANCY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; INCIDENCE; INFECTION PREVENTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MOULD; MYCOSIS; NONHUMAN; OVERALL SURVIVAL; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VARICELLA ZOSTER VIRUS; ALLOTRANSPLANTATION; AUTOTRANSPLANTATION; BLOOD DISEASE; DISEASE FREE SURVIVAL; FOLLOW UP; IMMUNE DEFICIENCY; MICROBIOLOGY; MIDDLE AGED; MORTALITY; STEM CELL TRANSPLANTATION; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; MYCOSES; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 64249107882     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-008-0184-2     Document Type: Article

References (37)

1. S Ascioglu JH Rex B de Pauw 2002 Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus Clin Infect Dis 34 7 14 10.1086/323335
2. L Pagano M Caira A Candoni 2006 The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study Haematologica 91 1068 75
3. EJ Bow 2008 Considerations in the approach to invasive fungal infection in patients with haematological malignancies Br J Haematol 140 133 52
4. PD Barnes KA Marr 2007 Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients Br J Haematol 139 519 31 10.1111/j.1365-2141.2007.06812.x
5. M Cornet L Fleury C Maslo JF Bernard G Brucker 2002 Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area J Hosp Infect 51 288 96 10.1053/jhin.2002.1258
6. DW Denning 1996 Therapeutic outcome in invasive aspergillosis Clin Infect Dis 23 608 15
7. SJ Lin J Schranz SM Teutsch 2001 Aspergillosis case-fatality rate: systematic review of the literature Clin Infect Dis 32 358 66 10.1086/318483
8. N Singh DL Paterson 2005 Aspergillus infection in transplant recipients Clin Microbiol Rev 18 44 69 10.1128/CMR.18.1.44-69.2005
9. A Bedini C Venturelli C Mussini 2006 Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital J Clin Microbiol 12 75 80
10. KA Marr RA Carter M Boeckh P Martin L Corey 2002 Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors Blood 100 4358 66 10.1182/blood-2002-05-1496
11. C Cordonnier P Ribaud R Herbrecht 2006 Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers Clin Infect Dis 42 955 63 10.1086/500934
12. C Lass-Flörl G Resch D Nachbaur 2007 The value of computed tomography-guided percutaneous lung biopsies in diagnosing invasive fungal infections in immunocompromised patients Clin Infect Dis 45 101 10.1086/521245
13. TF Patterson 2005 Advances and challenges in management of invasive mycoses Lancet 366 1013 25 10.1016/S0140-6736(05)67381-3
14. R Herbrecht DW Denning TF Patterson 2002 Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis N Engl J Med 347 408 15 10.1056/NEJMoa020191
15. CA Kauffman 2006 Clinical efficacy of new antifungal agents Curr Opin Microbiol 9 483 8 10.1016/j.mib.2006.08.001
16. M Boeckh HW Kim ME Flowers JD Meyers RA Bowden 2006 Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation-a randomized double-blind placebo-controlled study Blood 107 1800 5 10.1182/blood-2005-09-3624
17. KA Marr K Seidel MA Slavin 2000 Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial Blood 96 2055 61
18. KA Marr F Crippa W Leisenring 2004 Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants Blood 103 1527 33 10.1182/blood-2003-08-2644
19. H Einsele H Hebart G Roller 1997 Detection and identification of fungal pathogens in blood by using molecular probes J Clin Microbiol 35 1353 60
20. J Maertens K Theunissen T Lodewyck K Lagrou JV Eldere 2007 Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders Mycoses 50 2 17 10.1111/j.1439-0507.2007.01375.x
21. C Lass-Flörl E Gunsilius G Gastl M Freund MP Dierich A Petzer 2005 Clinical evaluation of Aspergillus-PCR for detection of invasive aspergillosis in immunosuppressed patients Mycoses 48 12 7 10.1111/j.1439-0507.2005.01104.x
22. TJ Walsh J Lee WE Dismukes 2002 Decisions about voriconazole versus liposomal amphotericin B N Engl J Med 346 1499 10.1056/NEJM200205093461915
23. J Mora-Duarte R Betts C Rotstein 2002 Comparison of caspofungin and amphotericin B for invasive candidiasis N Engl J Med 347 2020 9 10.1056/NEJMoa021585
24. KA Marr M Boeckh RA Carter HW Kim L Corey 2004 Combination antifungal therapy for invasive aspergillosis Clin Infect Dis 39 797 802 10.1086/423380
25. B Sendid A Cotteau N Francois 2006 Candidaemia and antifungal therapy in French University Hospital: rough trends over a decade and possible links BMC Infect Dis 6 80 10.1186/1471-2334-6-80
26. A Böhme M Ruhnke D Buchheidt 2003 Treatment of fungal infections in hematology and oncology-guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO) Ann Hematol 82 133 40 10.1007/s00277-003-0767-1
27. MJ Post C Lass-Flörl G Gastl D Nachbaur 2007 Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients Transpl Infect Dis 9 189 95 10.1111/j.1399-3062.2007.00219.x
28. A Cornillet C Camus S Nimubona 2006 Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and non neutropenic patients: a 6-year survey Clin Infect Dis 43 577 84 10.1086/505870
29. DW Denning A Marinus J Cohen 1998 An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group J Infect 37 173 80 10.1016/S0163-4453(98)80173-4
30. A Upton KA Kirby P Carpenter M Boeckh KA Marr 2007 Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality Clin Infect Dis 44 531 40 10.1086/510592
31. R Martino M Subira M Rovira 2002 Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients Br J Haematol 116 475 82 10.1046/j.1365-2141.2002.03259. x
32. KA Marr RA Carter F Crippa A Wald L Corey 2002 Epidemiology and outcome of mould infections in hematopoietic stem cell recipients Clin Infect Dis 34 909 17 10.1086/339202
33. D Cailliod O Casasnovas A Bernard 1997 Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery J Clin Oncol 15 139 47
34. SC Metcalf DH Dockrell 2007 Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts J Infect 55 287 99 10.1016/j.jinf.2007.06.012
35. EK Spanakis G Aperis G Mylonakis 2006 New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage Clin Infect Dis 43 1060 8 10.1086/507891
36. RY Hachem DP Kontoyiannis MR Boktour 2004 Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies Cancer 101 194 600 10.1002/cncr.20554
37. C Lass-Flörl M Fille E Gunsilius G Gastl D Nachbaur 2004 Disseminated infection with Prototheca zopfii after unrelated stem cell transplantation for leukemia J Clin Microbiol 42 4907 8 10.1128/JCM.42.10.4907- 4908.2004